Soleno Therapeutics (NASDAQ:SLNO) Now Covered by Analysts at Stifel Nicolaus
Investment analysts at Stifel Nicolaus started coverage on shares of Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) in a research note issued on Wednesday, Marketbeat reports. The brokerage set a “buy” rating and a $74.00 price target on the stock. Stifel Nicolaus’ price objective indicates a potential upside of 64.66% from the stock’s current price. […]
Investment analysts at Stifel Nicolaus started coverage on shares of Soleno Therapeutics (NASDAQ:SLNO – Get Free Report) in a research note issued on Wednesday, Marketbeat reports. The brokerage set a “buy” rating and a $74.00 price target on the stock. Stifel Nicolaus’ price objective indicates a potential upside of 64.66% from the stock’s current price. […]
